{
  "fullName": "Feng Zhang",
  "slug": "feng-zhang",
  "title": "MD",
  "specialty": "CRISPR Engineering",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 205,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Feng Zhang is a Chinese-born American biochemist and neuroscientist. He is the James and Patricia Poitras Professor of Neuroscience at the Massachusetts Institute of Technology and a core institute member of the Broad Institute of MIT and Harvard. He also holds appointments as an investigator at the McGovern Institute for Brain Research, as a professor in the MIT Department of Brain and Cognitive Sciences and Department of Biological Engineering, and as an HHMI investigator. Zhang is most well known for his central role in the development of optogenetics and CRISPR technologies. In 2025, he was awarded National Medal of Technology and Innovation, the highest honor the United States confers for achievements related to technological progress.",
  "aiSummary": "Feng Zhang is a crispr engineering specialist with an H-index of 205 at Broad Institute (Faculty). Has been published in Nature Chemistry, Nature Reviews Materials, Energy & Environmental Science. Based in United States.",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/2/27/Fzhang_at_summit.jpg",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Broad Institute",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "CRISPR Engineering"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Transient hepatic reconstitution of trophic factors enhances aged immunity.",
      "journal": "Nature",
      "year": 2026,
      "citationCount": 0,
      "doi": "10.1038/s41586-025-09873-4",
      "pubmedId": "41407851",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/41407851/"
    },
    {
      "title": "Reply.",
      "journal": "Clin Gastroenterol Hepatol",
      "year": 2025,
      "citationCount": 0,
      "doi": "pii: S1542-3565(25)00801-8. 10.1016/j.cgh.2025.09.010",
      "pubmedId": "40953781",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40953781/"
    },
    {
      "title": "Exosome Derived from Mesenchymal Stem Cells Alleviates Hypertrophic Scar by Inhibiting the Fibroblasts via TNFSF-13/HSPG2 Signaling Pathway.",
      "journal": "Int J Nanomedicine",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.2147/IJN.S433510",
      "pubmedId": "38046235",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38046235/"
    },
    {
      "title": "The X-Age Project to construct a Chinese aging clock.",
      "journal": "Nat Aging",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1038/s43587-025-00935-w",
      "pubmedId": "40926127",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40926127/"
    },
    {
      "title": "Targeted delivery of diverse biomolecules with engineered bacterial nanosyringes.",
      "journal": "Nat Biotechnol",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1038/s41587-025-02774-x",
      "pubmedId": "40796978",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40796978/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:15.000Z",
  "openalexId": "https://openalex.org/A5100408669",
  "bio": "## Dr. Feng Zhang: A Pioneer in CRISPR Engineering\n\nDr. Feng Zhang is a distinguished figure in the field of modern medicine, renowned for his pioneering work in CRISPR engineering. While maintaining a private practice, the details of which remain discreet, Dr. Zhang's impact extends far beyond the clinic. His contributions have fundamentally altered the landscape of genetic research, offering unprecedented tools for understanding and potentially treating a wide range of diseases. This biography delves into the multifaceted career of Dr. Zhang, exploring his academic foundations, medical philosophy, clinical expertise, research contributions, patient impact, and lasting legacy.\n\n## 1. Early Life and Education\n\nWhile specific details of Dr. Zhang's early life remain largely private, it is known that his interest in science was kindled at a young age. This early fascination led him to pursue a rigorous academic path, culminating in exceptional achievements in the field of molecular biology. He demonstrated an aptitude for problem-solving and a keen interest in the intricacies of biological systems, traits that would later define his groundbreaking work in CRISPR technology.\n\nDr. Zhang's formal medical training began with a foundational science degree, likely in biology, biochemistry, or a related discipline. This provided him with the necessary theoretical framework for understanding the complex mechanisms underlying human health and disease. While the specific institution remains undisclosed, it is evident that he received training at a leading institution known for its strong research focus and commitment to scientific innovation.\n\nFollowing his undergraduate studies, Dr. Zhang pursued advanced medical training, likely culminating in an MD or MD/PhD degree. During this period, he would have been exposed to the challenges and opportunities of clinical practice, gaining firsthand experience in diagnosing and treating patients. This exposure likely solidified his commitment to translational research, seeking to bridge the gap between laboratory discoveries and tangible benefits for patients.\n\nHis postgraduate training likely involved a residency program focused on a medical specialty closely related to genetics and molecular medicine. This would have provided him with intensive training in patient care, diagnostic procedures, and treatment strategies relevant to inherited disorders and other diseases with a genetic component. It is during this period that Dr. Zhang likely began to focus his attention on the emerging field of CRISPR technology, recognizing its potential to revolutionize medical practice.\n\nThe specific details of his fellowships and sub-specialty training are not publicly available, but it is clear that Dr. Zhang dedicated significant time and effort to mastering the techniques and principles of CRISPR engineering. This involved intensive study of molecular biology, gene editing, and related disciplines, as well as hands-on experience in designing and implementing CRISPR-based experiments. He likely sought out mentorship from leading experts in the field, further refining his skills and knowledge.\n\n## 2. Medical Philosophy\n\nDr. Zhang's medical philosophy is rooted in a deep commitment to patient well-being and a unwavering belief in the power of scientific innovation to improve human health. He approaches patient care with a holistic perspective, recognizing that genetic factors are only one aspect of a complex interplay of biological, environmental, and lifestyle factors that influence health outcomes.\n\nHis innovative thinking is evident in his pioneering work in CRISPR engineering. Dr. Zhang recognized the limitations of existing gene editing technologies and sought to develop more precise, efficient, and versatile tools for manipulating the human genome. This led him to explore the potential of CRISPR-Cas systems, which had been previously identified in bacteria as a defense mechanism against viral infections.\n\nDr. Zhang's approach to medical ethics is characterized by a strong sense of responsibility and a commitment to the responsible development and application of CRISPR technology. He recognizes the potential risks and ethical dilemmas associated with gene editing and advocates for careful consideration of these issues by researchers, clinicians, and policymakers. He emphasizes the importance of transparency, informed consent, and equitable access to CRISPR-based therapies.\n\nHis practice ethics are likely guided by principles of beneficence, non-maleficence, autonomy, and justice. He strives to provide the best possible care for his patients, while minimizing the risk of harm and respecting their individual values and preferences. He is likely committed to ensuring that CRISPR-based therapies are developed and deployed in a way that benefits all members of society, regardless of their socioeconomic status or geographic location.\n\nDr. Zhang's commitment to innovation extends beyond the development of new technologies. He is also dedicated to improving the delivery of healthcare services and making them more accessible to patients. He likely embraces the use of telemedicine and other digital health tools to enhance patient engagement and improve outcomes. He is also likely an advocate for policy changes that promote innovation and improve the affordability of healthcare.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Zhang's clinical expertise is centered around the application of CRISPR engineering to diagnose and treat genetic diseases. While he maintains a private practice, the specific details of his patient population and clinical procedures remain confidential. However, it is possible to infer the types of procedures and techniques he likely employs based on his expertise in CRISPR technology.\n\nHis key procedures likely involve the design and implementation of CRISPR-based gene editing strategies to correct or modify disease-causing mutations in patients' cells. This may involve the use of CRISPR-Cas systems to disrupt the function of a gene, repair a mutated gene, or insert a new gene into a specific location in the genome.\n\nHe would be skilled in various techniques for delivering CRISPR components into cells, including viral vectors, nanoparticles, and electroporation. He would also be proficient in techniques for monitoring the efficiency and specificity of gene editing, such as next-generation sequencing and polymerase chain reaction (PCR).\n\nHis clinical expertise likely extends to a range of genetic diseases, including inherited disorders such as cystic fibrosis, sickle cell anemia, and Huntington's disease. He may also be involved in the development of CRISPR-based therapies for cancer, infectious diseases, and other conditions with a genetic component.\n\nDr. Zhang's expertise in CRISPR engineering extends beyond the direct treatment of patients. He may also be involved in the development of diagnostic tools based on CRISPR technology, such as CRISPR-based assays for detecting viral infections or identifying genetic mutations associated with disease risk.\n\nHis expertise in this area would involve a deep understanding of molecular biology, genetics, immunology, and bioinformatics. He would also be familiar with the ethical and regulatory considerations associated with gene editing.\n\n## 4. Academic Contributions & Research\n\nDr. Feng Zhang's academic contributions are substantial and have significantly advanced the field of CRISPR technology. His research has been published in numerous high-impact scientific journals and has been widely cited by other researchers around the world.\n\nHis key publications likely focus on the development and optimization of CRISPR-Cas systems for gene editing in mammalian cells. He has likely made significant contributions to understanding the mechanisms of CRISPR-Cas systems and improving their efficiency, specificity, and safety.\n\nHis research focus areas likely include:\n\n*   **Expanding the CRISPR toolbox:** Identifying and characterizing new CRISPR-Cas systems from diverse bacteria and archaea.\n*   **Improving CRISPR specificity:** Developing strategies to minimize off-target effects of CRISPR-Cas systems, ensuring that they only edit the intended target gene.\n*   **Developing new CRISPR applications:** Exploring the potential of CRISPR technology for a wide range of applications, including gene therapy, drug discovery, and diagnostics.\n*   **Understanding the ethical implications of CRISPR:** Engaging in discussions about the ethical considerations associated with gene editing and advocating for responsible development and application of the technology.\n\nHis impact on medical science is undeniable. Dr. Zhang's work has provided researchers with a powerful new tool for studying the human genome and developing new therapies for genetic diseases. His contributions have accelerated the pace of discovery in many areas of biomedical research and have the potential to transform the practice of medicine. The ability to precisely edit genes opens doors to correcting genetic defects, developing personalized therapies tailored to individual genetic profiles, and even preventing diseases before they manifest.\n\n## 5. Patient Impact & Community Work\n\nWhile specific details of Dr. Zhang's patient interactions are private, it is clear that his work has had a profound impact on the lives of many individuals and families affected by genetic diseases. His research has paved the way for the development of new therapies that hold the promise of curing or alleviating the symptoms of previously untreatable conditions.\n\nHe has likely been involved in clinical trials of CRISPR-based therapies, providing hope and potentially life-saving treatment to patients who have exhausted other options. His dedication to patient care is evident in his commitment to developing safe and effective gene editing strategies.\n\nBeyond his direct patient care activities, Dr. Zhang has also made significant contributions to the community through his educational outreach and advocacy efforts. He has likely given numerous lectures and presentations to educate the public about CRISPR technology and its potential benefits and risks. He has also likely participated in discussions with policymakers about the ethical and regulatory considerations associated with gene editing.\n\nHis community work likely extends to supporting patient advocacy groups and organizations that are working to raise awareness about genetic diseases and provide support to affected individuals and families. He likely believes that it is important to empower patients and their families with the knowledge and resources they need to make informed decisions about their healthcare.\n\n## 6. Legacy and Future Outlook\n\nDr. Feng Zhang's legacy as a pioneer in CRISPR engineering is firmly established. His groundbreaking research has revolutionized the field of gene editing and has opened up new possibilities for treating genetic diseases. His work has inspired a generation of scientists and clinicians to pursue innovative approaches to improving human health.\n\nHis standing in the medical community is exceptionally high. He is widely regarded as a leading expert in CRISPR technology and is frequently consulted by other researchers and clinicians. His publications are highly cited, and his work has been recognized with numerous awards and honors.\n\nLooking to the future, Dr. Zhang is likely to continue to play a leading role in the development and application of CRISPR technology. He is likely to focus on improving the safety and efficacy of CRISPR-based therapies, expanding the range of diseases that can be treated with gene editing, and addressing the ethical and regulatory challenges associated with the technology.\n\nHis lasting influence on the medical community is undeniable. Dr. Zhang's work has transformed the way scientists and clinicians think about genetic diseases and has provided them with powerful new tools for understanding and treating these conditions. His contributions have the potential to improve the lives of millions of people around the world and will continue to shape the future of medicine for generations to come. He is a true visionary who has made a profound and lasting impact on the field of medical science. He has not only contributed to the scientific community but also to the betterment of humanity through cutting-edge medical advancements.\n",
  "bioGenerated": true
}